Allergy Asthma Respir Dis.  2019 Apr;7(2):106-108. 10.4168/aard.2019.7.2.106.

A case of nizatidine-induced immediate hypersensitivity

• Park SW
• Heo YJ
• Lee KS
• Kwon JW

• KMID: 2444844
• DOI: http://doi.org/10.4168/aard.2019.7.2.106

Abstract

Nizatidine is a histamine Hâ‚‚ receptor antagonist that inhibits stomach acid production and is commonly used in the treatment of peptic ulcer and gastroesophageal reflux. Hâ‚‚ receptor antagonists are typically well tolerated, and hypersensitivity reactions are rare. A 19-year-old woman developed urticaria 30 minutes after taking a drug containing nizatidine. Allergic reactions to nizatidine were confirmed via skin prick test, which also revealed cross-reactions to ranitidine. We believe that this is the first case report on immediate hypersensitivity to nizatidine in Korea.

Keyword

Nizatidine; Immediate hypersensitivity; Raniditine; Histamine Hâ‚‚ antagonists

MeSH Terms

Female
Gastroesophageal Reflux
Histamine
Humans
Hypersensitivity
Hypersensitivity, Immediate*
Korea
Nizatidine
Peptic Ulcer
Ranitidine
Skin
Stomach
Urticaria
Young Adult
Histamine
Nizatidine
Ranitidine

Figure

• 

  Fig. 1 Skin prick tests with nizatidine (duplicated).

Reference

1. Morton DM. Pharmacology and toxicology of nizatidine. Scand J Gastroenterol Suppl. 1987; 136:1–8.

2. Callaghan JT, Bergstrom RF, Rubin A, Chernish S, Crabtree R, Knadler MP, et al. A pharmacokinetic profile of nizatidine in man. Scand J Gastroenterol Suppl. 1987; 136:9–17.

3. Koskenpato J, Punkkinen JM, Kairemo K, Färkkilä M. Nizatidine and gastric emptying in functional dyspepsia. Dig Dis Sci. 2008; 53:352–357.

4. Foti C, Cassano N, Panebianco R, Calogiuri GF, Vena GA. Hypersensitivity reaction to ranitidine: description of a case and review of the literature. Immunopharmacol Immunotoxicol. 2009; 31:414–416.

5. Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des. 2008; 14:2778–2791.

6. Kim H, Yoon SH, Kim MH, Seol HY, Kim JE, Kim KU, et al. A case of ranitidine-induced anaphylaxis. Korean J Asthma Allergy Clin Immunol. 2010; 30:140–143.

7. Dumanović D, Juranić I, Dzeletović D, Vasić VM, Jovanović J. Protolytic constants of nizatidine, ranitidine and N,N'-dimethyl-2-nitro-1,1-ethenediamine; spectrophotometric and theoretical investigation. J Pharm Biomed Anal. 1997; 15:1667–1678.

8. Son BK, Lim DH. Allergic skin test. Korean J Pediatr. 2007; 50:409–415.

9. Feldman M, Burton ME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1. N Engl J Med. 1990; 323:1672–1680.

10. Lipsy RJ, Fennerty B, Fagan TC. Clinical review of histamine2 receptor antagonists. Arch Intern Med. 1990; 150:745–751.

11. Park KH, Pai J, Song DG, Sim DW, Park HJ, Lee JH, et al. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing. Clin Exp Allergy. 2016; 46:631–639.

12. Kim YI, Park CK, Park DJ, Wi JO, Han ER, Koh YI. A case of famotidine-induced anaphylaxis. J Investig Allergol Clin Immunol. 2010; 20:166–169.

13. Bossi A, Romeo G, Pezzoli A. Side-effects, structure, and H2-receptor antagonists. Lancet. 1992; 339:1366.

14. Song WJ, Kim MH, Lee SM, Kwon YE, Kim SH, Cho SH, et al. Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity. Allergy Asthma Immunol Res. 2011; 3:128–131.

15. Koh YI, Park HS, Choi IS. Ranitidine-induced anaphylaxis: detection of serum specific IgE antibody. Allergy. 2006; 61:269–270.

16. Cho YJ. Special review: update on the diagnosis of drug allergy. Korean J Med. 2009; 76:282–290.

17. Mira-Perceval JL, Ortiz JL, Sarrió F, Miralles JC, Hernández J, Negro-Alvarez JM, et al. Nizatidine anaphylaxis. J Allergy Clin Immunol. 1996; 97:855–856.

18. Morisset M, Moneret-Vautrin DA, Loppinet V, Grandidier S. Cross-allergy to ranitidine and nizatidine. Allergy. 2000; 55:682–683.